Blogs
Roche Holdings CEO Discusses Q3 2010 Results - Earnings Call Transcript -- Seeking Alpha
<p>Roche Holdings AG Basel (<a href='http://seekingalpha.com/symbol/rhhby.pk' title='Roche Holdings AG Basel'>RHHBY.PK</a>)</p><p>Q3 2010 Earnings Call</p><p>October 14, 2010 8:00 am ET</p><br/><a
Cancer treatment controls macular edema related to diabetes and to cataract surgery | Science Blog
Science Blog: Treating DMME with bevacizumab (Avastin), an anti-vascular endothelial growth factor (anti-VEGF) medication that inhibits abnormal blood vessels, was studied in115 patients (139 eyes) by the Pan-American Collaborative Retina Study Group, led by J. Fernando Arevalo, MD, of the Caracas
View From ASCO: Cancer Advances Made in Baby Steps « WebMD Newsroom
WebMD's editorial staff on the latest news from the world of health.
Another Setback for Roche's Cancer Drug -- Seeking Alpha
<strong><a href='http://www.burrillreport.com/'>The Burrill Report</a>submits:</strong><p><em>By Michael Fitzhugh<br></em></p><p>Avastin, Roche's (<a href='http://seekingalpha.com/symbol/rhhby.pk' title='Roche Holdings AG Basel'>RHHBY.PK</a>) phenomenally successful advanced cancer medicine, did
Roche: Another Avastin Setback -- Seeking Alpha
<strong><a href='http://www.burrillreport.com/'>The Burrill Report</a>submits:</strong><p><em><br></em></p><p><em>By Michael Fitzhugh</em></p><p>Avastin, Roche's (<a href='http://seekingalpha.com/symbol/rhhby.pk' title='Roche Holdings AG Basel'>RHHBY.PK</a>) phenomenally successful advanced cancer
ImmunoGen Suffers From the Second Lethal Virus -- Seeking Alpha
<strong><a href='http://www.prohostbiotech.com/'>Prohost Biotech</a>submits:</strong><p style="text-align: left;">Two lethal viruses plague general investors. The euphoria virus infects investors when the market stages sustained rallies. This virus makes investors buy and buy until the balloon
A Look at Immunogen Beyond the T-DM1 Setback -- Seeking Alpha
<strong>Ohad Hammer submits:</strong><p>The FDA’s decision to reject Roche’s (<a href='http://seekingalpha.com/symbol/rhhby.pk' alt='Roche Holdings AG Basel' title='Roche Holdings AG Basel'>RHHBY.PK</a>) filing for accelerated approval of T-DM1 had quite an impact on Immunogen’s
FDA Rightfully Rethinks Approval for Genentech / Roche Breast Cancer Drug -- Seeking Alpha
<img src='http://seekingalpha.com/wp-content/seekingalpha/images/dlowe73px.jpg' title='derek lowe' alt='derek lowe' width="73" height="87" align="left" hspace="6" vspace="6" border='1' /><strong><a href="http://pipeline.corante.com/">Derek Lowe</a>submits:</strong><div><div><div><div><p>As if one
Geron Corporation Q2 2010 Earnings Call Transcript -- Seeking Alpha
<p>Geron Corporation (<a href='http://seekingalpha.com/symbol/gern' alt='Geron Corporation' title='Geron Corporation'>GERN</a>)</p><p>Q2 2010 Earnings Call Transcript</p><p>July 30, 2010 11:00 am ET</p><br/><a
Roche Approaching High Stakes Avastin Breast Cancer FDA Approval Review -- Seeking Alpha
<strong><a href='http://www.epvantage.com/'>EP Vantage</a>submits:</strong><p>The review of<a href="javascript:;" rel="nofollow">Avastin</a>’s conditional US approval in first-line metastatic breast cancer later this month by an FDA advisory committee promises to be a high profile and high
Refine by Content Type:
Refine by Source:
- seekingalpha.com (27)
- blogs.webmd.com (11)
- www.scienceblog.com (1)
